CLINICAL_TRIALS
trial_result
· 2020-03-26
Clinical Trial Update: PET/CT-Assessment of Liver Tumor Ablation [NA]
Summary
Clinical trial update reporting PET/CT assessment of liver tumor ablation; study completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Dana-Farber Cancer Institute | Conditions: Liver Tumor, Liver Neoplasms | NA | Status: COMPLETED | Results posted: 2020-03-26